|
Sequani has over 30
years experience of performing safety and efficacy studies on
behalf of pharmaceutical and consumer product companies
worldwide. Over the past six years, we have carried out around
250 human programmes.
At Sequani we can
guide you through the regulatory maze and help develop
comprehensive strategic development programmes that take account
of the issues associated with the development of a medicinal
product.
Strong backing from
our support departments contributes to our ability to deliver high
quality reports swiftly. These departments include data management,
statistical support a dispensary and an archive that are all compliant with
Good Laboratory Practice guidelines. In addition, we have a
proactive molecular and investigative toxicology group that offers
in-vitro experience to further aid drug development
In conjunction
with our collaborative partners, our clinical services support
development from 'first- time-in-man through proof of concept up to
phase III, including clinical trials management, data management, biostatistical analysis,
centralised clinical laboratory testing, bioanalysis, formulation development, drug packaging
and distribution and regulatory affairs.
A clinical development
plan for an investigational medicinal product can follow a number
of approaches, depending on factors including the nature of the
product, its formulation, its proposed use, the quality and depth
of previous work and the therapeutic area.
At Sequani we
understand these issues and take them into account in helping you
develop tailored solutions. Our ultimate aim is to help you get
your product to market quicker whilst containing costs. |
